Search results with tag "Erlotinib"
DRUG NAME: Erlotinib - BC Cancer
www.bccancer.bc.caErlotinib BC Cancer Agency Cancer Drug Manual© Page 1 of 5 Erlotinib Developed: December 2005 Limited revision: 1 April 2009, 1 June 2010, 1 April 2011, 1 July 2014 DRUG NAME: Erlotinib
List of API Intermediates CAS No Intermediate Structure
www.synpurelabs.comList of API Intermediates Drug Name CAS No Intermediate Structure Dapiprazole 39512-51-1 1-(o-Tolyl) Piperazine HN N Erlotinib 6,7-dihydroxy quinazoline N N HO HO Erlotinib …
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euErlotinib is eliminated by hepatic metabolism and biliary excretion. Although erlotinib exposure was similar in patients with moderately impaired hepatic function (Child-Pugh score 7-9) compared with
Symptom Management Guidelines: ACNEIFORM …
www.bccancer.bc.ca• Patients ofAsian descent are found to be slightly more susceptible to symptom when taking Gefitinib, Erlotinib or Afatanib.
Tarceva - European Medicines Agency
www.ema.europa.euchanges to an approved test procedure PSUSA/1255/ 201711 Periodic Safety Update EU Single assessment - erlotinib 14/06/2018 n/a PRAC Recommendation - maintenance